Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

Clinical trial NCT03167411 · COMPLETED

Trial details

NCT number: NCT03167411
Sponsor: Theracos
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2017-05-24
Primary completion: 2017-06-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.